Medication info
Levosartan Tablet 2.5/80 mg

Levosartan Tablet 2.5/80 mg

Prescription medicationTabletOral
Ingredient · strength
Valsartan›80mg / 1 tabletS-Amlodipine Besylate 2.5 Hydrate›3.74mg / 1 tablet
Manufacturer / importer
AhnGuk Pharmaceutical Co., Ltd.
Appearance
Dark yellow round film-coated tablet
Packaging
30 tablets/bottle, 300 tablets/bottle
Approval status
Active

MFDS item code 201308538 · Approved 2013.07.30 · Insurance code 650204060

Summary

Main use
Treatment of essential hypertension not controlled with monotherapy
Who takes it
Adults · Children
Adult dose
The recommended dose of this medicine is 1 tablet once daily, taken with water, regardless of meals. It is recommended that it be taken at the same time each day, if possible (e.g., in the morning). Before starting this medicine, it is recommended that the dose be adjusted using the individual components (S-amlodipine (amlodipine) or valsartan). However, if blood pressure is not adequately controlled with monotherapy using the individual components as follows, switching directly to this medicine may be considered. ㆍ 2.5/80 milligrams: For patients whose blood pressure is not adequately controlled with monotherapy using S-amlodipine 2.5 milligrams (amlodipine 5 milligrams) or valsartan 80 milligrams. ㆍ 2.5/160 milligrams: For patients whose blood pressure is not adequately controlled with monotherapy using S-amlodipine 2.5 milligrams (amlodipine 5 milligrams) or valsartan 160 milligrams. ㆍ 5/160 milligrams: For patients whose blood pressure is not adequately controlled with monotherapy using S-amlodipine 5 milligrams (amlodipine 10 milligrams) or valsartan 160 milligrams, or with 2.5/160 milligrams. Patients taking valsartan and S-amlodipine (amlodipine) concomitantly may switch to this medicine (a combination product containing the same amount of each active ingredient) for convenience. Patients with renal impairment: No dosage adjustment is necessary in patients with mild or moderate renal impairment (creatinine clearance 10mL/min or greater); however, this medicine should not be administered to patients with severe renal impairment (creatinine clearance less than 10mL/min) or those undergoing dialysis. In patients with moderate renal impairment, monitoring of potassium levels and creatinine is recommended. Patients with hepatic impairment: In patients with mild or moderate hepatic impairment, the daily dose of valsartan should not exceed 80mg. This medicine should not be administered to patients with severe hepatic impairment, biliary cirrhosis, biliary obstruction, or cholestasis. Patients aged 65 years or older: Caution should be exercised when increasing the dose.
Child dose
The safety and efficacy of this drug have not been established in pediatric patients under 18 years of age; its use is not recommended.

Ingredients

Manufacturer
AhnGuk Pharmaceutical Co., Ltd.

Efficacy & effects

Treatment of essential hypertension not controlled with monotherapy

  • Essential hypertension
View approved original text

This medication is used for patients with essential hypertension when blood pressure control is insufficient with monotherapy of S-Amlodipine (Amlodipine) or Valsartan alone. By taking this medicine, it helps to effectively lower blood pressure by dilating blood vessels and improves heart and vascular health. This can reduce the risk of complications due to hypertension. Overall, it plays an important role in managing blood pressure consistently to help maintain a healthy daily life.

How to take

Adult dose

The recommended dose of this medicine is 1 tablet once daily, taken with water, regardless of meals. It is recommended that it be taken at the same time each day, if possible (e.g., in the morning). Before starting this medicine, it is recommended that the dose be adjusted using the individual components (S-amlodipine (amlodipine) or valsartan). However, if blood pressure is not adequately controlled with monotherapy using the individual components as follows, switching directly to this medicine may be considered. ㆍ 2.5/80 milligrams: For patients whose blood pressure is not adequately controlled with monotherapy using S-amlodipine 2.5 milligrams (amlodipine 5 milligrams) or valsartan 80 milligrams. ㆍ 2.5/160 milligrams: For patients whose blood pressure is not adequately controlled with monotherapy using S-amlodipine 2.5 milligrams (amlodipine 5 milligrams) or valsartan 160 milligrams. ㆍ 5/160 milligrams: For patients whose blood pressure is not adequately controlled with monotherapy using S-amlodipine 5 milligrams (amlodipine 10 milligrams) or valsartan 160 milligrams, or with 2.5/160 milligrams. Patients taking valsartan and S-amlodipine (amlodipine) concomitantly may switch to this medicine (a combination product containing the same amount of each active ingredient) for convenience. Patients with renal impairment: No dosage adjustment is necessary in patients with mild or moderate renal impairment (creatinine clearance 10mL/min or greater); however, this medicine should not be administered to patients with severe renal impairment (creatinine clearance less than 10mL/min) or those undergoing dialysis. In patients with moderate renal impairment, monitoring of potassium levels and creatinine is recommended. Patients with hepatic impairment: In patients with mild or moderate hepatic impairment, the daily dose of valsartan should not exceed 80mg. This medicine should not be administered to patients with severe hepatic impairment, biliary cirrhosis, biliary obstruction, or cholestasis. Patients aged 65 years or older: Caution should be exercised when increasing the dose.

Child dose

The safety and efficacy of this drug have not been established in pediatric patients under 18 years of age; its use is not recommended.

Precautions

This medication can cause serious harm to the fetus, especially during the second and third trimesters of pregnancy, so it must be discontinued immediately upon confirmation of pregnancy. It should not be administered to individuals with an allergy to the active ingredient or related components, pregnant or nursing women, patients with severe kidney or liver dysfunction, or patients with certain heart diseases. It may cause hypotension in patients with low sodium or fluid levels in the body, so the patient’s condition should be thoroughly checked before administration, and appropriate treatment should be provided if hypotension occurs. Patients with high potassium levels or those taking potassium supplements should have their potassium levels monitored frequently and exercise caution. Administration to patients with vascular issues related to the kidneys, those who have received kidney transplants, patients with a history of angioedema, or those recovering from heart failure or myocardial infarction should be done carefully while monitoring their condition closely. This medication can cause various side effects, with common symptoms including headache, dizziness, edema, and fatigue. Caution is advised when driving or operating machinery as dizziness or fatigue may occur. This medication may interact with other medicines, so be sure to inform healthcare providers of any medications currently being taken. Pregnant or nursing individuals are advised against taking this medication, and it is especially recommended to consult before taking it if planning to become pregnant. The safety and efficacy of this medication in pediatric patients have not been sufficiently established, and its use is not recommended. Elderly patients may be administered the standard adult dose; however, caution is necessary depending on their condition. In case of overdose, severe hypotension, dizziness, and tachycardia may occur, necessitating immediate medical attention. During treatment with this medication, regular monitoring of blood pressure, kidney function, electrolyte levels, etc., is necessary to check for any abnormal signs.

Side effects

nasopharyngitis, influenza, hypersensitivity, visual impairment, anxiety, headache, dizziness, drowsiness, orthostatic dizziness, paresthesia, vertigo, tinnitus, tachycardia, palpitations, syncope, orthostatic hypotension, hypotension, cough, pharyngeal and laryngeal pain, diarrhea, nausea, abdominal pain, constipation, dry mouth, rash, erythema, hyperhidrosis, itching, joint swelling, low back pain, arthritis, muscle spasms, lethargy, polyuria, nocturia, erectile dysfunction, edema, localized edema, facial edema, peripheral edema, fatigue, flushing, weakness, facial flushing, decreased hemoglobin, decreased hematocrit, neutropenia, thrombocytopenia, hypersensitivity including serum sickness, increased serum potassium, vasculitis, elevated liver function tests, angioedema, myalgia, renal failure, kidney damage, increased serum creatinine, insomnia, decreased libido, pharyngitis, rhinitis, sinusitis, upper respiratory tract infection, viral infection, intestinal vascular edema, diplopia, thrombocytopenia, leukopenia, allergic reaction, hyperglycemia, insomnia, mood changes, tremors, sensory impairment, taste disorder, peripheral neuropathy, hypertonicity, arrhythmia, bradycardia, atrial fibrillation, ventricular tachycardia, myocardial infarction, vasculitis, dyspnea, rhinitis, vomiting, dyspepsia, pancreatitis, gastritis, gingival hyperplasia, hepatitis, jaundice, alopecia, purpura, skin depigmentation, photosensitivity reaction, angioedema, urticaria, erythema multiforme, Stevens-Johnson syndrome, myalgia, micturition disorders, nocturnal enuresis, gynecomastia, pain, lethargy, chest pain, weight loss, weight gain, elevated liver enzymes, chest discomfort, abdominal discomfort, gastroesophageal reflux, neck pain, hypercholesterolemia, hypoglycemia, neuroirritability, Stevens-Johnson syndrome, arthralgia, skeletal pain, rhabdomyolysis, gingival hyperplasia, gastritis

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly sealed container to protect it from exposure to air or moisture. Additionally, it should be stored at room temperature between 1 and 30 degrees Celsius, avoiding areas that are too hot or too cold.

Appearance and packaging

Appearance

Dark yellow round film-coated tablet

Package unit

30 tablets/bottle, 300 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.